Researchers analyzed 102 eyes of 51 patients, finding that nearly three-fourths demonstrated signs of ocular involvement.
Observing that ocular involvement is common among patients with rosacea, researchers have published their recent findings that also suggest a possible connection between the severity of ocular involvement and certain cutaneous symptoms.
Findings were published in Turkish Journal of Ophthalmology.
The researchers analyzed 102 eyes of 51 patients, finding that nearly three-fourths (74.5%) of patients demonstrated signs of ocular involvement, in line with previous findings. Signs of ocular involvement included lid margin erythema and telangiectasias; anterior blepharitis and meibomian gland dysfunction; styes and chalazia; corneal erosion, vascularization, and thinning; scleritis and sclerokeratitis.
Among the 38 patients with ocular signs, the most commonly observed signs were lid margin erythema (100%), meibomian gland dysfunction (94.7%), and blepharitis (73.7%). There were 15 patients who had diminished eye function from rosacea-related complications, including leukoma and corneal neovascularization, 3 (7.9%) of which required keratoplasty.
Notably, the researchers found that among the patients with the weakest eye function resulting from rosacea corneal involvement, there was a significant association with rhinophyma, papules, and pustules.
“As it has been mentioned before, rosacea manifests with relapses and remissions. Special attention should be given to ocular involvement during exacerbations, as progression of skin disease could lead to more severe ocular damage. Early referral to the ophthalmologist in these cases might prevent visual loss,” posited the researchers
They further noted that there is no gold standard for diagnosing ocular involvement in rosacea and every patient may have some level of ocular compromise.
Among the patients included in the study, most were women, and the average age of presentation was 50 years.
Treatments for the patients included in the study comprised artificial tears (65.8%), oral doxycycline (60.5%), corticosteroid-antibiotic ointment (57.9%), and lid hygiene (39.5%). Close to 8.0% required a corneal transplant, resulting from decreased visual acuity.
“We identified 2 cases of associated OCP [ocular cicatricial pemphigoid] in patients with ocular rosacea. This suggests that these 2 diseases can coexist. OCP is an autoimmune disease that involves a type 2 hypersensitivity reaction,” wrote the researchers. “Both environmental factors and genetic susceptibility might be involved in loss of tolerance to the components of the basement membrane zone. As has been proposed for other diseases that may coexist with OCP, ocular surface injuries related to rosacea could expose basement membrane epitopes of damaged conjunctiva, which might act as neoantigens that precipitate the autoimmune response.”
Reference
Saá F, Cremona F, Chiaradia P. Association between skin findings and ocular signs in rosacea. Turk J Ophthalmol. 2021;51(6):338-343. doi:10.4274/tjo.galenos.2021.05031
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Research Shows Prior Authorization Denials Delay Critical Immunology Care
May 10th 2024Results featured at the Academy of Managed Care Pharmacy 2024 annual meeting revealed a pattern of prior authorization rejections that could delay necessary therapeutic treatments for various patient groups.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Patients With Advanced, Recurrent Melanoma May Experience Lasting AEs From ICM Therapy
May 9th 2024A cross-sectional, mixed-methods study found that adverse effects (AEs) can occur even after 1 year of treatment with immune checkpoint modulator (ICM) therapy in patients with melanoma.
Read More